Dou Y - Search Results

1

Author Correction: Quiescence enables unrestricted cell fate in naive embryonic stem cells.

Khoa LTP, Yang W, Shan M, Zhang L, Mao F, Zhou B, Li Q, Malcore R, Harris C, Zhao L, Rao RC, Iwase S, Kalantry S, Bielas SL, Lyssiotis CA, Dou Y. Khoa LTP, et al. Among authors: dou y. Nat Commun. 2024 Mar 12;15(1):2215. doi: 10.1038/s41467-024-46566-4. Nat Commun. 2024. PMID: 38472240 Free PMC article. No abstract available.

2

ASH2L regulates ubiquitylation signaling to MLL: trans-regulation of H3 K4 methylation in higher eukaryotes.

Wu L, Lee SY, Zhou B, Nguyen UT, Muir TW, Tan S, Dou Y. Wu L, et al. Among authors: dou y. Mol Cell. 2013 Mar 28;49(6):1108-20. doi: 10.1016/j.molcel.2013.01.033. Epub 2013 Feb 28. Mol Cell. 2013. PMID: 23453805 Free PMC article.

3

H2B ubiquitylation promotes RNA Pol II processivity via PAF1 and pTEFb.

Wu L, Li L, Zhou B, Qin Z, Dou Y. Wu L, et al. Among authors: dou y. Mol Cell. 2014 Jun 19;54(6):920-931. doi: 10.1016/j.molcel.2014.04.013. Epub 2014 May 15. Mol Cell. 2014. PMID: 24837678 Free PMC article.

4

Hijacked in cancer: the KMT2 (MLL) family of methyltransferases.

Rao RC, Dou Y. Rao RC, et al. Among authors: dou y. Nat Rev Cancer. 2015 Jun;15(6):334-46. doi: 10.1038/nrc3929. Nat Rev Cancer. 2015. PMID: 25998713 Free PMC article. Review.

5

Characterization and pharmacologic targeting of EZH2, a fetal retinal protein and epigenetic regulator, in human retinoblastoma.

Khan M, Walters LL, Li Q, Thomas DG, Miller JM, Zhang Q, Sciallis AP, Liu Y, Dlouhy BJ, Fort PE, Archer SM, Demirci H, Dou Y, Rao RC. Khan M, et al. Among authors: dou y. Lab Invest. 2015 Nov;95(11):1278-90. doi: 10.1038/labinvest.2015.104. Epub 2015 Aug 17. Lab Invest. 2015. PMID: 26280220 Free PMC article.

6

Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy.

Peng D, Kryczek I, Nagarsheth N, Zhao L, Wei S, Wang W, Sun Y, Zhao E, Vatan L, Szeliga W, Kotarski J, Tarkowski R, Dou Y, Cho K, Hensley-Alford S, Munkarah A, Liu R, Zou W. Peng D, et al. Among authors: dou y. Nature. 2015 Nov 12;527(7577):249-53. doi: 10.1038/nature15520. Epub 2015 Oct 26. Nature. 2015. PMID: 26503055 Free PMC article.

7

MLL1 Inhibition Reprograms Epiblast Stem Cells to Naive Pluripotency.

Zhang H, Gayen S, Xiong J, Zhou B, Shanmugam AK, Sun Y, Karatas H, Liu L, Rao RC, Wang S, Nesvizhskii AI, Kalantry S, Dou Y. Zhang H, et al. Among authors: dou y. Cell Stem Cell. 2016 Apr 7;18(4):481-94. doi: 10.1016/j.stem.2016.02.004. Epub 2016 Mar 17. Cell Stem Cell. 2016. PMID: 26996599 Free PMC article.

8

PRDM16 Suppresses MLL1r Leukemia via Intrinsic Histone Methyltransferase Activity.

Zhou B, Wang J, Lee SY, Xiong J, Bhanu N, Guo Q, Ma P, Sun Y, Rao RC, Garcia BA, Hess JL, Dou Y. Zhou B, et al. Among authors: dou y. Mol Cell. 2016 Apr 21;62(2):222-236. doi: 10.1016/j.molcel.2016.03.010. Epub 2016 Apr 14. Mol Cell. 2016. PMID: 27151440 Free PMC article.

9

The Targetable Epigenetic Tumor Protein EZH2 is Enriched in Intraocular Medulloepithelioma.

Avedschmidt SE, Stagner AM, Eagle RC Jr, Harocopos GJ, Dou Y, Rao RC. Avedschmidt SE, et al. Among authors: dou y. Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6242-6246. doi: 10.1167/iovs.16-20463. Invest Ophthalmol Vis Sci. 2016. PMID: 27842164 Free PMC article.

10

EpiDenovo: a platform for linking regulatory de novo mutations to developmental epigenetics and diseases.

Mao F, Liu Q, Zhao X, Yang H, Guo S, Xiao L, Li X, Teng H, Sun Z, Dou Y. Mao F, et al. Among authors: dou y. Nucleic Acids Res. 2018 Jan 4;46(D1):D92-D99. doi: 10.1093/nar/gkx918. Nucleic Acids Res. 2018. PMID: 29040751 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,993 results

Search Page

Filters